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Foreword 
Public Health England (PHE) is a research-informed organisation that is driving 
forwards the provision and use of evidence for decision-making across our public health 
system. Research relevant to health and care is thriving due to sustained investment 
and new, productive relationships among researchers and those who would use their 
findings. In PHE we have taken a fresh look at the role of research and knowledge - or 
evidence - in supporting public health locally, nationally and internationally.  
 
Public Health England does not commission research. Our mandate from Government, 
agreed with the Department of Health, refers to ‘undertaking and contributing to 
research and development in areas relevant to its functions’.  
 
We have four core functions:  
 
• protecting the population’s health from infectious diseases and other hazards  
• improving population health and wellbeing and reducing inequalities  
• improving population health through sustainable health and care services  
• building the capability and capacity of the public health system  
 
Each function must be underpinned by world-class scientific evidence drawn laboratory 
and clinical sciences, behavioural and social sciences, data sciences, and others. On 
occasion, we will commission external support to compile, analyse and present the 
evidence base on specific topics. 
 
This document sets out PHE’s commitment to research, translation and innovation; the 
steps we will take, alone or with partners, to do research, to support research and to 
use evidence from research. In 2014 we published ‘From Evidence into Action: 
opportunities to protect and improve the nation’s health’, in which we indicated that ‘new 
evidence and new knowledge…could transform the scope of public health’ and made a 
commitment to ensure that ‘credible, evidence-based advice is available on the key 
issues relating to the public’s health’. Our research, translation and innovation activities 
will enable us to do that.  
 
The intended PHE, national and global audiences for this document are:  
 
• researchers, research commissioners and funders 
• policy-makers 
• public health practitioners and providers, including primary care and the voluntary 
sector 
• local government organisations 
• higher education institutions 
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• industry 
• the public 
 
We are most grateful to the many individuals and organisations who participated in our 
public consultation on this strategy. Many responses were substantial, all were valuable 
and we undertook a careful analysis of your comments. The final strategy is much 
improved as a result.  
 
  
 
 
Professor David Heymann 
Chairman 
Duncan Selbie  
Chief Executive 
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Executive summary 
This strategy document sets out how Public Health England (PHE) will drive research, 
translation and innovation to support the transformation of public health practice and 
services. Its success will lie in close working across (public) health and care, academia 
and the private sector. 
 
The remit, services and priorities of PHE that address the protection of the public and 
prevention of disease are, necessarily, broad. The level of achievement in research and 
related activities and its state of development vary considerably across the 
organisation’s different functional areas; by far the greatest strengths are in Health 
Protection: Infectious Diseases and Chemical, Radiation and Environmental threats. 
Nonetheless, implementation of this strategy is intended to advantage all areas, drawing 
support from, and providing assistance to many local, national and international partner 
organisations. 
 
This strategy addresses five priorities:  
 
• knowledge  
• infrastructure  
• capacity  
• innovation  
• communication  
 
For each priority, specific objectives are defined and the actions to be taken by PHE are 
set out. These are 
 
Priority one: knowledge - generate new knowledge to improve and protect health  
 
Objectives: 
 
1. Undertake research that peer reviewers commend as being of the highest quality 
and leads opinions through publications in the internationally-acclaimed scientific 
literature. 
2. Focus researchers in PHE and elsewhere on research questions relevant to the 
evidence needed for public health. 
3. Apply diverse research methodologies appropriate for the range and complexity 
of public health research questions and contribute to methodological 
development. 
4. Value and evaluate evidence from diverse sources and use it systematically to 
improve public health. 
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PHE will: 
 
• support and undertake high quality research relevant to more aspects of its remit 
• support interactions among researchers, research funders, research users and the 
public to agree and disseminate priority research questions 
• support the development and function of partnerships with major research groups 
• provide high quality evidence products and support the development of skills to use 
evidence 
 
Priority two: infrastructure – build, share and sustain high-quality infrastructure 
to enable research by PHE and others  
 
Objective: 
 
PHE will advance its engagement with, and support of, national enabling 
infrastructure for public health research 
 
PHE will: 
 
• continue its strong support for the National Institute for Health Research (NIHR) 
Health Protection Research Units (HPRUs) both to achieve evidence for PHE 
actions and to build research capacity, capability and excellence, leveraging the 
initial investment 
• add value to networks of significant external partners who share a commitment to 
undertaking high quality research relevant to public health and using research and 
evidence to improve health outcomes 
• invest in, deploy and share sophisticated research facilities, equipment and 
expertise 
• continually enhance the efficiency of data provision for research, add value to data 
resources and work with partner organisations towards the same goals 
• work with partner organisations to ensure effective, efficient governance 
arrangements for research and related activities 
 
Priority three: capacity – support development of public health research capacity 
in PHE and elsewhere and inspire public health research careers 
 
Objectives: 
 
1. Embed development of research capabilities and leadership in workforce development 
initiatives. 
2. Support academics in public health through engagement with PHE. 
3. Provide career-long research training for public health researchers. 
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PHE will: 
 
• have a clear view and action plan to support research in the careers of PHE staff 
• maintain and extend its Academic Public Health Research Network 
• extend the range of research training opportunities across different areas of PHE 
and different career stages 
• work with partner organisations to highlight and support a co-ordinated clinical – 
academic career pathway for public health 
 
Priority four: innovation - accelerate translation of research into policy and 
practice in public health and commercial products 
 
Objectives: 
 
1. Develop a PHE model for translation of evidence into policy or practice. 
2. Develop a PHE process to enable robust evaluation of public health interventions. 
3. Work with partner organisations and the private sector to support economic 
development. 
 
PHE will: 
 
• establish in-house and partnership support systems for successful innovation by 
translating evidence into policy or practice, learning from best practice nationally and 
internationally 
• support the robust evaluation of public health interventions including close 
interaction with partner organisations so as to contribute to effective decision-making 
by providers of public health services  
• enhance its track record and profile in the translation of research evidence into 
commercial opportunities 
 
Priority five: communication - communicate widely and openly about how 
research is contributing to improving and protecting health and wellbeing and 
reducing health inequalities  
 
Objectives: 
 
1. Lead and contribute to evidence-based public health narratives, nationally and 
internationally. 
2. Enhance the accessible, public profile of PHE’s Research, Translation and Innovation 
functions and achievements. 
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PHE will: 
 
• maintain a dialogue on public health research, organising, participating in and 
contributing to discussion fora nationally and internationally 
• publish annual reviews of PHE’s research, translation and innovation activities 
 
For each objective, measures of success are set out that will be evident both within 
PHE and externally. 
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Definitions 
The following definitions of the terms ‘research’, ‘translation’ and ‘innovation’ apply 
throughout this document. 
 
Research is an attempt to derive generalisable and/or transferrable new 
knowledge by addressing clearly defined questions with systematic, rigorous and 
repeatable methods. 
 
Translation is a process of adding value to robust evidence so that it may be 
used. 
 
Innovation is a process that brings together various novel ideas in a way that 
they have an impact (on public health). 
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The strategic context 
PHE is an executive agency of the Department of Health, but with operational 
autonomy. PHE provides the public health system with strong leadership, helping to 
make an effective and unified public health response to emergencies, supporting those 
responsible for delivery with the evidence, data and tools to make a real difference to 
the health of communities.  
 
To fulfil the duty of the Secretary of State for Health to protect the public’s health from 
infectious diseases and other public health hazards, PHE works with the NHS, local 
government and other key partners including the devolved administrations and 
internationally, as appropriate.  
 
PHE also functions to secure improvements to the public’s health, including through 
evidence-based interventions, working with its partner organisations. And PHE 
contributes to ensuring that the public health system maintains the capability and 
capacity to tackle today’s public health challenges while preparing for future challenges.  
 
In 2014 PHE published ‘From evidence into action: opportunities to protect and improve 
the nation’s health’1 highlighting where it believes it can make the greatest impact on 
the public’s health in addition to the delivery of mandated services. To galvanise and 
direct efforts, it focuses on seven strategic priorities aimed at improving the public’s 
health: alcohol, antimicrobial resistance, dementia, obesity, tobacco, tuberculosis and 
giving every child the best start in life. The importance of focusing on prevention is 
reinforced by the ‘Five year Forward View’2 published by NHS England, PHE and other 
health sector partners. 
 
PHE’s Knowledge Strategy3 was published in June 2014. The intention to develop a 
research strategy was indicated and, in setting out a knowledge cycle (Figure 1), 
research was placed within a continuum of public health knowledge creation and use. 
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Figure 1: public health knowledge cycle 
 
As an organisation with a deep commitment to providing and using knowledge, PHE 
operates alongside, and engages strategically and operationally with, partner 
organisations locally, nationally and internationally who undertake, support and use 
research. Opportunities for progress set out in the research strategies of a range of 
policy and funding organisations are highly relevant. The most significant is ‘Best 
Research for Best Health’4 from the National Institute for Health Research (NIHR). 
NIHR is funded through the Department of Health, England (DH) to improve the health 
and wealth of the nation through research. Its strategy has been implemented 
successfully since its publication in 2006, transforming health research by providing 
consistent growth through significant investment in enabling infrastructure, major 
applied research programme, research careers and the involvement of patients and the 
public. In parallel, DH supports high quality research relevant to policy, mostly notably 
through the Health Research Programme Policy Research Units (HRP PRUs). Both the 
DH and NIHR significantly enable research in PHE and across the complex multi-
organisational, multi-disciplinary public health landscape.  
 
Among UK research councils, strategies of the Medical Research Council (MRC 
‘Research Changes Lives’5) and Economic and Social Research Council (ESRC ‘Social 
Science Shaping Society6) are highly relevant for research to meet the evidence needs 
of PHE. While PHE, as a civil service organisation, cannot lead proposals for research 
council funding, it can add value to research as a partner organisation and significantly 
enhance opportunities for research impact as articulated by MRC and ESRC. Likewise 
other public sector organisations and major health research charities nationally and 
internationally have set out their strategic plans. PHE will continue to engage with them 
to support implementation and provide input to future strategic thinking. 
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Leadership in patient and public involvement and engagement (PPI/E) in research is a 
hallmark of UK health research. The part of NIHR that supports active involvement of 
people in NHS, public health and social care research is INVOLVE. The INVOLVE 
strategy is being refreshed currently, however in a report of a review led by its chairman 
‘Going the extra mile: improving the nation’s health and wellbeing through involvement 
in research’, a vision is set out of ‘A population actively involved in research to improve 
health and wellbeing for themselves, their family and their communities.’ PHE will work 
to support the achievement of that vision. 
 
For more than a decade, collaboration has been a hallmark of UK health research 
funders. This has enabled many highly beneficial strategic initiatives. The UK Clinical 
Research Collaboration (UKCRC) was established in 2004 to re-engineer the UK 
clinical research environment. The UKCRC brings together research funders from the 
public, private and charitable sectors with regulatory bodies and users of research 
findings that include industry, healthcare provider organisations, patients and the public. 
It has given rise to a range of highly beneficial reports and initiatives. These include the 
UK Health Research Analysis reports that provide detailed profiles of the UK’s 
investment in health research, enabling insight and action. For example, understanding 
of the need to invest in illness prevention spurred development of the National 
Prevention Research Initiative (NPRI) and establishment of the UKCRC Centres of 
Excellence in Public Health. PHE aims to play a full part in future strategic 
developments. 
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Current significant PHE research activities  
PHE produces evidence from research and uses evidence across all of its remit. Its 
formation in April 2013 brought together a range of functions and organisations that 
varied in their depth and scope of research and legacy of research achievements. A 
focus of the current strategy is to share good practice, expertise, experience and 
support across all parts of the organisation so that all functional areas have a good 
research base. 
 
A light-touch review was undertaken of research and related activities in the first year of 
PHE’s operation, 2013/14. Principal findings were: 
 
• some £35M in funding invested of which more than £29.5 million was attracted from 
external research funders 
• £8.5M of the external research funding was from sources outside the UK 
• excluding abstracts, book chapters etc and reports, 857 peer-reviewed publications 
comprised part of PHE’s advice and guidance functions - spanning more than 300 
different journal titles, this total indicates the considerable breadth of PHE’s 
engagement with research; all publications included at least one author employed by 
PHE (albeit that some author affiliations were to PHE’s predecessor organisations). 
• publications and other output that informed significant developments in policy and 
practice 
 
This high level of productivity was sustained throughout 2014, eg with a total of more 
than 1,000 peer reviewed publications. 
 
The most significant research concentration relates to infectious disease. To 
consolidate and accelerate capacity and capability in that area and others for the future, 
an excellent platform has now been established in 13 NIHR Health Protection Research 
Units. The competitive selection process involved rigorous peer review including a high-
level international panel that reviewed documentation/presentations and conducted 
interviews. Funding for five years was awarded to 13 units that commenced operation in 
April 2014. Eleven units are theme-specific while two are cross-cutting. PHE is a partner 
in each of the 13 NIHR HPRUs as shown in the table below, as well as being a user of 
the research outcomes and expertise to be developed in the units.  
 
The work programme of each NIHR HPRU is set out in a business plan agreed among 
its partners. Their governance is the responsibility of an Oversight Group convened by 
the DH and on which PHE is represented. The specific research themes being pursued 
are detailed in Annex A. 
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PHE’s response to the 2014-15 Ebola outbreak in West Africa included work on virus 
characterization, vaccine development, the deployment of resources in affected 
countries and the UK, modelling of the outbreak and its likely impact and strategies for 
recovery and rebuilding in its aftermath. The research capabilities of PHE and its 
partners, particularly within several NIHR HPRUs, contributed significantly to this work 
and continues to do so. Major publications and other beneficial outputs are emerging 
and will be added to well into the future.  
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Table 1. NIHR Health Protection Research Units 
 
 
Priority Area Lead University and other partners (with PHE) 
Environmental change and health London School of Hygiene & Tropical Medicine 
Exeter University, University College London 
Health impact of environmental 
hazards 
King’s College London 
Imperial College London 
Emergency preparedness and 
response 
King’s College London 
Newcastle University, University of East Anglia 
Chemical and radiation threats 
and hazards 
Newcastle University 
Emerging infections (including 
zoonoses) and biological threats 
University of Liverpool 
Liverpool School of Tropical Medicine 
Immunisation London School of Hygiene & Tropical Medicine 
Respiratory infections Imperial College London 
Imperial College NHS Trust and Birmingham University 
Gastrointestinal infections University of Liverpool 
University of East Anglia, University of Oxford, Institute of 
Food Research 
Blood-borne and sexually 
transmitted Infections 
University College London 
London School of Hygiene & Tropical Medicine 
Healthcare associated infections 
and antimicrobial resistance 
Imperial College London 
Wellcome Sanger Institute, NWL Academic Health 
Science Network, Cambridge Veterinary School 
University of Oxford 
Animal and Plant Health Agency 
Development of modelling 
methodology 
Imperial College London 
Evaluation of interventions University of Bristol  
University College London, Cambridge MRC Biostatistics 
Unit, University of the West of England 
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Our strategic priorities for research, 
translation and innovation 
Our five priorities are: 
 
• knowledge - generate new knowledge to improve and protect health  
• infrastructure – build, share and sustain high-quality infrastructure to enable 
research by PHE and others  
• capacity – support development of public health research capacity in PHE and 
elsewhere and inspire public health research careers 
• innovation - accelerate translation of research into policy and practice in public 
health and commercial products 
• communication - communicate widely and openly about how research is 
contributing to improving and protecting health and wellbeing and reducing health 
inequalities  
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Priority One 
Knowledge - generate new knowledge to improve and protect health 
 
Objectives: 
 
undertake research that peer reviewers commend as being of the highest quality and leads 
opinions through publications in the internationally-acclaimed scientific literature  
 
1. focus researchers in PHE and elsewhere on research questions relevant to the evidence 
needed for public health 
2. apply diverse research methodologies appropriate for the range and complexity of public 
health research questions and contribute to methodological development  
3. value and evaluate evidence from diverse sources and use it systematically to improve 
public health 
 
Undertake research that peer reviewers commend as being of the highest quality 
and achieves publication in the internationally-acclaimed scientific literature  
 
PHE includes areas of activity with excellent track records of success in securing 
research funding through competitive peer review and in achieving publication. It is 
recognized however that while we participate in many projects, our record of research 
leadership can be improved. Further, the majority of external awards relate to health 
protection research and, of almost 1,000 peer reviewed publications achieved each 
year, the majority concern health protection. Funding opportunities to contribute to the 
development and evaluation of public health interventions include the MRC Public 
Health Intervention Development programme and NIHR Public Health Research 
Programme, respectively; however the project portfolios of many other funding schemes 
include a diverse array of public health research.  
 
To enhance its research performance relevant to a wider proportion of PHE’s remit, 
greater support will be provided to develop external funding proposals, achieve 
publications in the scientific literature and develop partnerships with academia. This 
support will be differentiated according to the current state of research capacity and 
capability in specific areas of PHE. All areas will be encouraged to develop action plans 
aligned to this current strategy, to work towards attainable targets and to monitor and 
report on their achievement. 
 
In some aspects of its work, eg emergency preparedness and response, PHE invests its 
own funding for research. The quality of all such research will be assured through 
regular external reviews by panels involving external, expert peers. The outcomes of 
reviews will inform future funding decisions.  
 
PHE will: support and undertake high quality research relevant to more of its remit 
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Measures of success:  
 
1. The number of high quality, peer reviewed publications, led by PHE authors. 
2. The number, value and success rate of proposals for external research funding that are 
led by PHE staff.  
3. The number of PHE staff who are named applicants on proposals for external research 
funding. 
4. Developmental measures to include: members of PHE staff achieving their first peer 
reviewed publication, first research conference keynote presentation and/or first external 
research funding.  
 
Focus researchers in PHE and elsewhere on research questions relevant to the 
evidence needed for public health 
 
Robust evidence for research is essential across all areas of PHE’s remit and only a 
small proportion can be done by PHE’s own staff. To highlight areas of research need 
and gain consensus across the sector, PHE convenes workshops and related activities 
involving leading researchers, research funders, PHE programme leads and others with 
responsibility for policy and service delivery. Workshop outputs highlight the most 
important research questions and necessary developments in research infrastructure 
and support. An initial workshop series focused on the PHE priorities set out in ‘From 
Evidence to Action’ while others concern discrete PHE programmes. Workshop reports 
will be disseminated widely.  
 
Achieving consensus on research priorities is a key function of the James Lind Alliance, 
part of the NIHR. The process generally involves the formation of priority-setting 
partnerships (JLA PSPs), for example with health (research) charities that engage 
patients and/or carers affected by particular illnesses. To build upon that important work 
and enable multi-disciplinary approaches to illness prevention, PHE will seek to develop 
a PSP-like methodology so that members of the public can contribute to priority setting. 
An important partner for PHE will be INVOLVE, one of the few government funded 
programmes of its kind in the world that supports the patient and public involvement and 
engagement in research (PPI/E).  
 
PHE will: support interactions among researchers, research funders, research users 
and the public to agree and disseminate priority research questions  
 
Measures of success:  
 
1. The range of research priority topics influenced by PHE. 
2. Innovative community involvement in research prioritization exercises and subsequent 
research. 
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Apply diverse research methodologies and disciplines appropriate for the range 
and complexity of public health research questions and contribute to 
methodological development  
The breadth and complexity of public health research presents considerable challenges 
and opportunities for innovation. Knowledge and methodologies drawn from many 
different disciplines eg quantitative analysis of large datasets and descriptive 
epidemiology; genomics and behavioural psychology, may need to be combined and 
placed within real-world contexts to address particular questions. And high quality 
information science should underpin all research. The necessary expertise cannot 
always be provided by PHE’s own staff so must be deployed through collaboration with 
academics locally, nationally and internationally.  
 
PHE will seek to form partnerships involving diverse support mechanisms, including 
finance, access to data, specialist facilities and resources or other in - kind 
contributions. Short-term staff exchanges – secondments – between partners will be 
advocated and facilitated to assist in disseminating research skills from academia and 
helping them to understand the contexts in which research findings can have impact. 
 
Through the EU’s European Commission, the Horizon 2020 and health programmes, 
PHE supports major research and innovation projects involving multiple academic, other 
public sector and private sector partners. Parts of PHE, predominantly in Health 
Protection areas, have excellent track records of success in EU programmes. The 
current opportunities include a focus on ‘Societal Challenges’, with topics such as 
ageing, illness prevention, reducing inequalities etc, so there is scope for PHE 
involvement across the breadth of its remit. The need to translate research findings into 
real impact is fundamental to most programmes. Therefore PHE, with its roles in 
delivering and supporting public health interventions locally and nationally, is an 
excellent partner in EU research consortia. 
 
PHE will: support the development and maintenance of partnerships with major 
research groups  
 
Measures of success: 
 
1. Active partnerships with universities and other research organisations. 
2. Number of staff exchanges between PHE and partners. 
3. Number and success rate of proposals to external research funders, including EU 
programmes, which involve PHE. 
 
Value and evaluate evidence from diverse sources and use it systematically to 
improve public health 
 
Public health practice and policy encompass many opportunities to collate useful 
evidence in addition to that acquired through conventionally-structured research 
projects. This real-world evidence can be essential particularly when judging whether 
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the results of research are applied more generally and more widely than the specific 
study itself or the appropriateness of using evidence in the design of novel 
interventions. Whatever the sources of the evidence or method by which it is gathered, 
the skills to evaluate it are essential. PHE will work closely with respected organisations, 
eg Cochrane Collaboration or the Critical Appraisal Skills Programme (CASP), to 
contribute to and draw from the evidence base and develop skills such as those for 
evidence appraisal or systematic reviewing within its own staff. PHE can also influence 
the wider public health sector by involving staff, eg those from local authorities, in 
training or other programmes designed to enhance skill for the evaluation and use of 
evidence.  
 
PHE has a role in the preparation and dissemination of evidence products to 
organisations and practitioners across the sector. In this, it works closely with the 
National Institute for Health and Care Excellence (NICE) that also has a strong public 
health function. Joint working includes agreement on systematic taxonomy of different 
products and outputs. To ensure the high quality of its evidence products, a PHE 
publication standard has been developed (Figure 2) and the requirement to achieve that 
quality standard will be embedded across the organisation.  
 
PHE will: develop the skills of the public health sector by providing high quality evidence 
products and supporting the development of skills to use evidence  
 
Measures of success: 
 
1. The number of PHE evidence products that achieve its quality standard 
2. The usage by external organisations of PHE evidence products and esteem in which 
they are held 
3. The number of PHE staff and local authority public health staff who are trained in 
evidence information retrieval, appraisal, reviewing etc  
 
Figure 2 PHE publication standard process 
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Priority Two 
Infrastructure – build, share and sustain high-quality infrastructure to enable research 
by PHE and others 
 
Infrastructure for excellent health and care research is now widely available nationally. 
Public health is no exception although improvements to the available infrastructure are 
always possible through partnerships and dedicated funding streams.  
 
Infrastructure is supported through diverse investments from a wide range of major 
health research funders based in the UK or internationally. The NIHR in particular has 
established, supports and provides access to a comprehensive infrastructure, 
coordinated by the NIHR Office for Clinical Research Infrastructure (NOCRI).  
 
Objective: 
 
• enhanced PHE engagement with, and support of, national enabling infrastructure for 
public health research, including: 
 
1. Significant external support (eg NIHR Health Protection Research Units). 
2. Significant networks (eg NIHR School for Public Health Research; NIHR School for 
Primary Care Research; NIHR School for Social Care Research; Collaborations for 
Leadership in Applied Health Research and Care (CLAHRCs); Academic Health Science 
Networks (AHSNs)). 
3. Access to dedicated expertise and resources to undertake studies (eg clinical research 
networks (CRNs), clinical trials units (CTUs), specialist laboratory facilities, equipment 
and staff, expertise including statistics, data analysis, health economics, information 
science etc). 
4. Health, care and other population-based datasets/linked data. 
5. Research governance support. 
 
Significant external support, eg NIHR Health Protection Research Units 
 
The major NIHR infrastructure investments build upon a substantial track record of 
successful projects and the commitment of recognised leaders. Most of PHE’s past 
success in external funding relates to Health Protection – whether infectious disease or 
chemical, radiation or other environmental hazards. A step change in infrastructure 
support in these areas is provided by the five-year, £47.5 million NIHR Health Protection 
Research Unit (HPRU) initiative. Thirteen NIHR HPRUs were established in 2013 with 
the aim of supporting PHE to achieve its objectives and functions for the protection of 
the public’s health. PHE are full partners in each Unit. Table 1 shows the NIHR HPRU 
partners and research themes that were selected through a highly-competitive, 
international, peer review process. In each case, responsibility for delivering the agreed 
work programmes, managing the units and reporting to funders lies with a university-
based director (an internationally-recognised leader in the relevant area), working with 
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designated PHE lead(s). Each NIHR HPRU also provides capacity to respond to 
research needs emerging through PHE’s work.  
 
PHE will: continue its strong support for the NIHR HPRUs both to achieve evidence for 
PHE actions and to build research capacity, capability and excellence, leveraging the 
initial investment  
 
Measures of success: 
 
1. The number of high quality papers published and postgraduate students supervised in 
NIHR HPRU projects with PHE staff as named authors or supervisors. 
2. Evidence of impact on public health nationally and internationally. 
3. Other markers of research esteem gained by PHE staff, eg invited keynote presentations 
at major conferences, review articles, journal editorships or leadership of subsequent 
major initiatives. 
4. Leverage of the NIHR investment in HPRUs through external research funding achieved 
by PHE. 
 
Significant networks, eg NIHR School for Public Health Research; NIHR School 
for Primary Care Research; NIHR School for Social Care Research; 
Collaborations for Leadership in Applied Health Research and Care (CLAHRCs); 
Academic Health Science Networks (AHSNs)  
 
The NIHR schools are nation-wide networks of university members with significant 
experience of research relevant to the health and care system. Their emphasis on 
translational research and innovation or ‘what works practically’ makes them important 
partners for PHE, the NIHR School for Public Health Research (SPHR) in particular. 
The schools enable access to senior investigators with significant experience of 
leadership and commitment in many topics across public health for which evidence, and 
the use of evidence is essential. The NIHR SPHR is strongly engaged locally and so 
offers a supportive infrastructure to complement the geographical reach of PHE and its 
local authority partners. That engagement includes involvement in a number of 
CLAHRCs. The AHSNs are designated as ‘system integrators’ across public and private 
health sectors to align various pathways towards improved health outcomes, including 
the adoption of new technologies. Further development of a focus on illness prevention 
among AHSNs, and progress in the application of technology to public health, eg digital 
health technologies, should yield future opportunities for beneficial engagement, 
including wealth-creation aspects such as product development. 
 
PHE will: add value to networks of significant external partners who share a 
commitment to using research and evidence to improve health outcomes  
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Measures of success: 
 
1. Number of projects underway involving PHE and member(s) of NIHR Schools, 
CHLARCs and/or AHSNs. 
2. Number of projects involving PHE and network partners working with local authorities. 
3. Recognition as a valued participant in AHSN initiatives. 
4. External income realized by PHE through engagement with networks. 
 
Access to dedicated expertise and resources to undertake studies, eg clinical 
research networks (CRNs), clinical trials units (CTUs), specialist laboratory 
facilities, equipment and staff, expertise including statistics, data analysis, health 
economics etc 
 
The diversity of PHE’s scientific services and research requires provision of, and access 
to, highly specialized physical and human resources and continual investment in their 
maintenance and upgrading. Nonetheless, to meet the health protection from chemical, 
biological, radiation or natural hazards and scientific/technological advances, the 
necessary facilities or skills are not always available in-house in appropriate time-
scales. Many other organisations face similar challenges so it is both efficient and 
expedient to establish ongoing arrangements for mutual access and collaboration.  
 
As part of the UK’s response to the 2014 to 2015 Ebola outbreak in West Africa, 
research and translation by PHE helped to characterize the virus at genomic level 
and develop vaccines. That was possible only with laboratory facilities of the 
highest safety and containment level, specialist scientific expertise and 
experience of working successfully in global networks. 
 
Consistency in the availability and quality of physical or staff resources and expertise is 
essential for high quality, cost-effective research. Major investment by NIHR in CRNs, 
CTUs and other research support services, and investment by a range of other funders, 
is of significant value to PHE’s work in aspects of infectious disease, including 
immunisation. PHE has a significant experience of conducting, and working with others 
on, clinical trials that inform government policy on immunisation for illnesses that include 
influenza, TB and a wide range of childhood immunisation programmes. There is an 
opportunity to formalise arrangements and resources, ensuring that PHE plays a full 
part in the Infectious Diseases and Microbiology Specialty of the NIHR CRN. 
 
As a major step-up in its scientific capability, PHE has planned its Science Hub as a 
significant development over the next decade. Opportunities to advance research are 
envisaged together with support for economic development, engaging the private 
sector. The proposed greater involvement in existing networks, including AHSNs in 
many parts of the country, will advantage PHE’s aspirations.  
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PHE has submitted an outline business case to government to develop a Public 
Health Science Hub with a preferred location of Harlow, in Essex between London 
and Cambridge. The ambition is that The Hub will be a centre for most of PHE’s 
national scientific functions bringing together expertise into a single location, 
strengthening our scientific functions and research base. The Hub will work 
closely with a series of nodes across the country enabling a nation-wide network 
of research-active practitioners, drawing on the national centre of expertise and 
specialist facilities. 
 
Expertise that exists and is being developed both in-house and with academic and 
policy partners includes behavioural insights and health economics. Such expertise 
facilitates innovation by informing decisions about implementing novel, cost-effective 
interventions. The availability of relevant, scarce expertise also attracts investment from 
the private sector and contributes to economic development. 
 
PHE will: invest in, deploy and share sophisticated research facilities, equipment and 
expertise  
 
Measures of success: 
 
1. Return on investment in PHE’s own research facilities, equipment and expertise. 
2. Number of projects undertaken by PHE, alone or with partners that involve NIHR CRN. 
3. Number and success rate of research proposals involving PHE that include CTU 
support. 
4. Step-up in research activity as the Science Hub is realised. 
5. Evidence of impact on policy, practice or product development. 
 
Health, care and other population-based datasets/linked data 
 
The UK has an exceptional wealth of health datasets and considerable work underway, 
by a range of organisations, to maximize the value of these assets for research to 
benefit people, services and the economy. Responsibility for the datasets lies with a 
number of organisations that include PHE and other principals: 
 
• the Health and Social Care Information Centre (HSC IC) 
• Clinical Practice Research Datalink (CPRD) 
• NIHR Health Informatics Collaborative (NIHR HIC) 
 
Ongoing collaboration among these organisations aims to create shared processes and 
IT infrastructures. This work will also engender trust among the potential users about 
the accessibility and quality of the data and among the public about the robustness of 
confidentiality and governance arrangements. PHE has integrated and developed 
single, national disease registries, initially in cancer and congenital anomalies, 
deploying significant resources and expertise that will also be applied to additional 
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disease and treatment areas. An Office for Data Release has been established to 
respond to requests from researchers, operating within an appropriate data governance 
framework. PHE must be acknowledged in any ensuing publications or presentations. 
The development of mutually beneficial arrangements for data sharing with statutory 
holders of data, including the Health and Social Care Information Centre (HSC IC), 
continues apace.  
 
For its core functions of collating and analysing data and information from across the 
(public) health and care system and making it available to health and care provider 
organisations, PHE recruits and develops staff with deep and broad expertise in 
statistics and data analysis. These staff add value to the data that may be accessed for 
research. Significant advantages for research are also enabled through routinely 
collated, population-level datasets. When appropriate, specific data sets may also be 
linked with those managed by the Office of National Statistics. 
 
Current major PHE data assets: 
 
• national registers – cancer, congenital anomaly and rare diseases  
• clinical audit data  
• data from screening programmes – cancer, vascular disease, antenatal and new born 
disease, diseases in childhood  
• microbiology laboratory data 
 
 
Future opportunities for PHE and for academic researchers include partnerships with 
major UK investments in data science expertise and IT capability. 
 
Using routinely-collected data, PHE works with researchers at many institutions 
nationally and internationally on the Global Burden of Disease (GBD) initiative. Its 
application to understanding the burden of disease and disability across regions of 
England is highly innovative and will contribute to the support provided to local 
authorities.  
 
PHE will: continually enhance the efficiency of data provision for research, add value to 
data resources and work with partner organisations towards the same goals  
 
Measures of success: 
 
1. The number of quality research publications enabled by data shared by PHE. 
2. The number and achievements of partnerships between PHE and major data science 
initiatives (funded projects, successful postgraduate training, publications and impact on 
policy or practice). 
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Research governance support 
 
It is important that researchers receive clear, consistent messages on how to achieve 
good governance for their proposed project. For public health, studies capable of 
supporting policy or practice, nationally or internationally may be clearly recognisable as 
research or may straddle the boundaries with related activities such as service 
evaluations.  
 
PHE is working closely with the Health Research Authority (HRA) that was established 
to protect and promote the interests of patients and the public in health research and to 
streamline the regulation of research. The HRA ensures that health research is ethically 
reviewed and approved, including the provision of information so that people can make 
an informed decision about whether to participate or not. This helps to build public 
confidence in health research.  
 
To support research led by PHE staff, a Research Governance Review Group has been 
established with an independent chair and membership that includes HRA and lay 
people. The remit of the group is to review PHE-led research and service evaluation 
proposals that involve human participants, their data and/or their tissues, advising on 
appropriate routes to ethics review and conformity with relevant legislation including, but 
not limited to, that covering data protection, confidentiality, freedom of information, the 
Human Tissue Act and applicable regulatory standards such as ‘good clinical practice’. 
As much research in PHE involves academic partners, processes of a collaborating 
university may be an appropriate route to good governance so such solutions will be 
recognised. The Group will also advise on whether PHE should act as sponsor for 
particular studies.  
 
A register of studies involving PHE will be maintained to provide assurance that all 
research meets the necessary governance standards to minimise risks to the 
organisation, to its staff as investigators and to people who consent to be study 
participants. 
 
PHE will: work with partner organisations to ensure effective, efficient governance 
arrangements for research and related activities  
 
Measures of success: 
 
1. Researchers in PHE receive efficient, authoritative advice on the pathways to ensuring 
good governance. 
2. PHE has clear, timely reports on governance arrangements for all projects that involve 
its staff, facilities or resources. 
3. PHE has clear, timely reports on its commitments as a research sponsor. 
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Priority Three 
Capacity – support development of public health research capacity in PHE and 
elsewhere and inspire public health research careers  
 
Objectives: 
 
1. Embed development of research capabilities and leadership in workforce 
development initiatives. 
2. Support academics in public health through engagement with PHE. 
3. Provide career-long research training for public health researchers. 
 
Embed research in workforce development initiatives 
 
The size and diversity of the public health workforce requires concerted action to ensure 
sufficient commitment to research and prevent the loss of valuable expertise. PHE, 
universities, research funders and professional organisations each have parts to play. 
Support must be available at all career stages. PHE supports many workforce initiatives 
and it is important that there is adequate focus on research skills, including research 
management and leadership. 
 
Health Education England (HEE) has set out its Research and Innovation strategy8. It 
advocates whole-system cultural change in doing and using research and innovation, 
scoping and accessing best practice in research training and developing a multi-
professional research careers framework. To achieve its aims, HEE will work with 
health, and care sector partners as well as universities, much the same as those 
indicated throughout this PHE strategy. Thus HEE will be a key partner for PHE, 
working together and with others to apply its vision and framework to research careers 
in public health.  
 
PHE has set out its Public Health Workforce Strategy that includes a focus on research, 
consistent with that in the HEE Research and Innovation strategy. Actions being taken 
forward include improving the co-ordination of existing support and resources; 
supporting academic PH through specialty training; facilitating the entry of PH staff into 
research and research career development.  
 
The European Commission offers a range of programmes for individuals and institutions 
for short-term and longer-term staff exchanges with EU and other countries. These help 
to stimulate research and innovation through training and acquisition and dissemination 
of skills and expertise. While the UK is extremely active in such programmes, to-date 
PHE has been minimally involved. Increased participation can be highly beneficial both 
to the organization and to individual staff. 
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PHE will: have a clear view and action plan to support research in careers in public 
health  
 
Measures of Success 
 
1. Completion of an organisation-wide scoping exercise. 
2. Staff in PHE can access support for research training and performance at all career 
stages. 
3. PHE participates in EU-funded researcher training and mobility programmes. 
 
 
Support academic public health 
 
PHE has established a nationwide Academic Public Health Research Support Network, 
based largely upon the holders of honorary contracts from PHE. Oversight of the 
contributions made by contract holders includes input to their job planning and 
appraisal, working alongside their academic managers. The roles and responsibilities of 
institutions that employ the honorary contract-holders have now also been formalised 
through collaborative agreements.  
 
An overview of the areas of expertise covered by holders of honorary contracts is now 
possible following a mapping exercise. This enables PHE staff to access the necessary 
support for particular functions. Gaps in the current expertise can also be identified and 
action taken to identify suitable academics. Annual network events for honorary contract 
holders enable closer engagement with PHE, raising mutual awareness of relevant 
topics. 
 
Much academic expertise of value to PHE is in disciplines where individuals typically do 
not hold honorary contracts so future partnership development will extend into all 
academic disciplines relevant to specific PHE programmes of work.  
 
The outcomes of the 2014 UK Research Excellence Framework (REF 2014) 
demonstrated strength, depth and relevance in public health research activity, and 
improvements relative to the previous REF (2008), in many universities around the UK. 
Combining this with the geographical dispersal of PHE and its local authority partners 
provides a sound basis for local research development. Such development would 
enable a focus on locally-relevant research questions, but with research quality 
sufficient to compete for funding nationally or internationally. Funded research projects 
would enhance the recruitment and retention of research staff, development of research 
expertise and opportunity for research to inform practice and services throughout the 
country. Integration into a national network would help to ensure a flow of robust, 
generalizable findings to stimulate innovation in other locations.  
 
PHE will: maintain and extend its Academic Public Health Research Network  
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Measures of success: 
 
1. Number of holders of PHE honorary contracts who are involved in research with PHE. 
2. Number and value of research projects involving PHE and local authorities with local 
universities. 
3. Evidence of increased flow of research findings into local public health interventions. 
 
Career-long research training for public health researchers 
 
Research training supported by PHE currently involves funding of PhD studentships 
through competitive selection of projects led by PHE researchers, normally with 
academic partners. In many cases, project leads secure matched, or partial, funding of 
the studentships from external sources – essential given the small size of the PhD 
funding resource. Most studentships are held in scientific (laboratory) positions and are 
undertaken by full-time students, recruited openly, who register with a partner university. 
While that programme is important to attract highly able graduates into public health 
research, the modes and topics of study need to be broadened to provide opportunities 
for other disciplines and individuals. 
 
A positive driver for change is the wish among some individual staff to pursue 
postgraduate research awards of benefit to PHE as well as their own careers. It is 
appropriate for the organisation to encourage and support motivated individuals, to help 
them undertake study and research training on topics of benefit to PHE’s remit and to 
vary their workload to facilitate study. 
 
New opportunities might include: 
 
• increased range of PHE disciplines funded to offer PhD projects. 
• supported part-time doctoral study, including opportunities for existing PHE staff. 
• support for professional doctorates. 
• a formal research training framework with modules offered by PHE alongside 
academic partners, appropriate to postgraduate, post-doctoral and more advanced 
research stages. 
 
While the individual student in training is necessarily the focus of a PhD supervisory 
team, teams that include both PHE and university staff with a range of expertise and 
experience can enable productive mutual learning and acquisition of skills across the 
wider team. 
 
Opportunities to learn about other research activities, to celebrate research 
achievements and to gain experience in presenting research findings are organised by 
PHE for its PhD students. It is important that such offerings embrace all those working 
towards postgraduate research awards, whether supported through PHE’s own PhD 
scheme or otherwise 
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PHE’s desire to engage more substantially in the health research ecosystem, including 
success in competition for major funding, requires enhanced capability and capacity for 
research leadership and management. This focus has been a core feature in developing 
the strength of UK clinical research, particularly through NIHR support. PHE will work to 
develop opportunities for senior staff to participate in such programmes. 
 
PHE will: extend the range of research training opportunities across different areas of 
PHE and different career stages  
 
Measures of success: 
 
1. Number of full-time and part-time research students who spend a substantial proportion 
of their programme in PHE, including PHE staff. 
2. Number of PHE staff who are involved in doctoral student supervision. 
3. A well-subscribed programme of internal and external research training available to all 
full-time and part-time PHE research students and staff. 
4. Number of PHE staff who participate in training for research leadership. 
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Priority Four 
Innovation – accelerate translation of research into policy and practice in public health 
and commercial products  
 
Objectives: 
 
1. Develop a PHE model for translation of evidence into policy or practice.  
2. Develop a PHE process to enable robust evaluation of public health interventions. 
3. Work with partner organisations and the private sector to support economic 
development. 
 
Develop a PHE model for translation of evidence into policy or practice  
 
A wealth of research relevant to public health is underway in the UK and globally and 
the existing literature is extensive. Different studies have been consistent in showing a 
considerable lag-period - some 17 years - between the initiation of research and the 
uptake of findings into policy or practice. A great diversity of robust findings from public 
health research can be drawn upon when designing innovate policies or interventions, 
but the many sources of possibly useful evidence also create complexity.  
 
For the REF 2014, participating universities submitted case studies to demonstrate how 
their research made an impact on society, eg on policy or practice. Universities also set 
out strategic commitments to build future impact. PHE is an excellent conduit to 
achieving impact for universities because of its growing ability to use evidence to deliver 
programmes, its proximity to local authorities and its remit to advise government on 
evidence.  
 
The translation of research findings into policy or practice is in itself a major source of 
enquiry in many countries. Disciplines such as implementation science have developed 
in scope and methodologies though their predominant focus is on clinical care. 
Nonetheless various health/care systems globally have progressed evidence translation 
approaches to benefit their public health services. It is extremely important for PHE to 
identify and engage with exemplars of best practice internationally. 
 
PHE will: establish in-house and partnership support systems for successful innovation 
by translating evidence into policy or practice, learning from best practice nationally and 
internationally  
 
Measures of success: 
 
1. Adoption of a ‘PHE Evidence Translation Model’. 
2. Number of PHE or local authority public health interventions developed or amended by 
translation of research evidence. 
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3. Number of impact case studies involving PHE that will be developed for university 
submissions to the next REF, in 2020. 
 
Develop a PHE process to enable robust evaluation of public health interventions 
 
The development of novel interventions must be accompanied by robust evaluation 
frameworks. The outcomes of evaluations then inform decisions on future 
redevelopment or refinement of the interventions and their cost-effectiveness. The NIHR 
School for Public Health Research (SPHR) has developed a highly innovative 
programme – the Public Health Practice Evaluation Scheme (PHPES), that selects local 
authority-delivered interventions, matches them with appropriate academic expertise 
from among its member institutions, and supports a two-year evaluation. The initiative 
also adds value by surrounding each ongoing evaluation with a learning network to 
disseminate evaluation expertise.  
 
Despite the relevance and excellence of the PHPES, there is capacity to deliver only a 
small number of evaluations annually. PHE will develop in-house support for 
evaluations, corralling a range of known expertise and working closely with the 
developing health economics programme. 
 
Major research funders, specifically NIHR and MRC in addition to a range of charities, 
have specific schemes dedicated to the implementation of findings and their evaluation. 
These schemes will be targeted by PHE, alone and with academic partners. 
 
PHE will: contribute to effective decision-making by providers of public health 
interventions through robust evaluation of public health programmes 
 
Measures of success: 
 
1. Adoption of a ‘PHE Intervention Evaluation Process’. 
2. Number of successful evaluations of interventions in line with the PHE process. 
3. Number of successful PHPES evaluations where there is PHE involvement. 
 
Work with partner organisations and the private sector to support economic 
development 
 
PHE has a diversity of resources, expertise and assets – whether biological materials 
such as cells or microorganisms or datasets – that can add significant value to 
commercial enterprises. Many successes have been achieved and income realised for 
the organisation by investing in research activities and enhancing the delivery of routine 
PHE services. 
 
In the digital sector, innovation in personal and population health monitoring, eg of 
behaviours such as physical activity to prevent illness, is driving commercial innovation 
and development. The precise shape or success of future business models is yet 
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unclear. For PHE there are opportunities to integrate novel digital capabilities into public 
health research programmes and to support decision-making about their deployment by 
providing evidence from research and evaluation. 
 
The proposed enhanced interaction with AHSNs will facilitate engagement with the 
private sector and facilitators of innovation.  
 
PHE will: enhance its track record and profile in the translation of research evidence into 
commercial opportunities  
 
Measures of success: 
 
1. Number of innovative products based on research evidence from PHE. 
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Priority Five 
Communication – communicate widely and openly about how research is contributing 
to improving and protecting health and wellbeing and reducing health inequalities  
 
Objectives: 
 
1. Lead and contribute to evidence-based public health narratives, nationally and 
internationally. 
2. Enhance the accessible, public profile of PHE’s Research, Translation and Innovation 
functions and achievements. 
 
Lead and contribute to evidence-based public health narratives, nationally and 
internationally 
 
Already PHE communicates widely about its research, most notably via authorship of 
some 1,000 articles annually in the scientific literature as well as many other evidence-
led reports, guidelines, briefings etc, but this excellent productivity must be 
accompanied by communication of research expertise and potential more widely within 
PHE and the wider public health research system, to potential research partners and 
users of research and to the public. The re-development of PHE’s own digital 
communication channels (intranet and internet) present an opportunity as does the 
dissemination of many types content via social media, including supported professional 
networks.  
 
Part of PHE’s remit is to provide evidence-led advice to government. By developing 
research questions based on evidence gaps, using the findings from subsequent 
research and highlighting the contributions of the research, PHE would be well-placed 
to ensure that high quality, authoritative advice is communicated. This is also a route to 
impact on policy-making. Again, this underlines the value of PHE in mobilizing evidence 
from research. 
 
Components of a national dialogue in public health research are woven through this 
strategy. PHE will engage with academic, professional, government, local authority and 
other public and private sector opinion-leaders and publish its views, as appropriate, 
through conventional and digital channels. Relevant topics would include:  
 
• research priorities and questions 
• research infrastructure and other funding opportunities 
• translation of evidence from research into public health policies and practices 
• economic value of public health research 
• value and impact of evidence 
• involvement and engagement of people, patients and communities 
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PHE will: maintain a dialogue on public health research, organising, participating in and 
contributing to discussion for a nationally and internationally 
 
Measures of success: 
 
1. Enhanced profile for PHE as a reliable source of high quality, evidence-led 
publications/products. 
2. Internal and external communications of strength and achievements in research and 
related activities. 
 
 
Enhance the accessible, public profile of PHE’s Research, Translation and 
Innovation functions and achievements  
 
A PHE directory of expertise will be compiled, focussing primarily on research expertise, 
and made publicly accessible. 
 
Many staff of PHE hold dual affiliations, eg PHE and academic institutions. It is 
important always to detail PHE involvement when authoring any publications. This 
drives the profiling of PHE’s activities and outputs, particularly through digital literature 
searching or content extraction, helping to increase the rate of citation of PHE staff 
publications and the wider use of research findings. 
 
A review of PHE’s research, translation and innovation activities will be undertaken and 
published annually to illustrate the value to public health, contributions to income and 
workforce and impact on public health research more widely. 
 
PHE will: publish annual reviews of PHE’s research, translation and innovation activities  
 
Measures of success: 
 
1. External use of a PHE directory of expertise. 
2. Reports published of annual reviews of PHE Research, Translation and Innovation. 
 
36 
Doing, supporting and using public health research 
 
Implementation 
This strategy has set out the principal actions that will be taken by PHE and how 
success will be measured.  
 
To advise and support its implementation, an External Advisory Board (EAB) will be 
established. Chaired by a non-executive member of PHE Board with significant 
research experience, the EAB will include research leaders from academia and the 
wider public health sector in the UK and internationally, senior members of staff with 
research responsibility from public sector organisations with analogous responsibilities 
to those of PHE and members of the public. The Board is expected to meet annually to 
review achievements and support future progress. The Board will make 
recommendations to the Deputy Director for Research, Translation and Innovation in 
addition to a report to PHE’s chief executive. 
 
Within PHE, an organisation-wide group (currently titled PHE R&D Group) will agree 
specific metrics with each PHE directorate/major research groupings and monitor their 
achievements. Where appropriate, the Group will advise on actions or initiatives that 
might accelerate progress and support the deputy director for research, translation and 
innovation to implement these.  
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Annex A 
NIHR Health Protection Research Units 
 
 
NIHR HPRU  Themes 
Environmental 
change and health 
Climate resilience 
Healthy sustainable cities 
Health and the natural environment 
 
Health impact of 
environmental 
hazards 
Epidemiological assessment of low-level environmental exposures 
Modes and mechanisms of chemical toxicity 
Health impact of low dose non-ionising and ionising radiation 
Health impacts of noise and air pollution including nanoparticles 
Emergency 
preparedness and 
response 
Wellbeing during and after a major incident  
The behavioural impact of emergency communication 
Syndromic surveillance for early detection of incidents  
The evidence base for risk assessment and risk reduction 
The operational effectiveness of skin decontamination in exposure to 
toxic chemicals 
Biomarkers in detection and triage 
Enhancing emergency preparedness through improved 
exercises/training 
Chemical and 
radiation threats 
and hazards 
Health effects of medical radiation exposures  
Skin and barrier function in radiation and chemical exposures   
Chemical exposures and the development of primary biliary cirrhosis 
Acute and chronic chemical exposure and neurological and psychiatric 
disorders   
Emerging infections 
(incl. zoonoses) and 
biological threats 
Risk assessment of emerging and zoonotic threats 
Epidemiological approaches 
Clinical surveillance 
Pathogen discovery and characterisation 
Vector biology and climate modelling 
Immunisation Vaccine effectiveness and safety, disease burden and equity in health 
using linked electronic health records 
Systematic reviews, modelling and cost effectiveness 
Policy, communications, implementation and vaccine acceptability  
Respiratory 
infections 
Influenza surveillance, severity/pathogenesis 
Influenza immunology and virology 
TB surveillance, screening and diagnostics Acute respiratory infections 
Respiratory syncytial virus 
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NIHR HPRU  Themes 
Gastrointestinal 
infections 
People: exploring socio-economic and behavioural factors in GI 
infections 
Tracking disease in the population: developing novel methods for 
disease surveillance and outbreak investigation 
Pathogens: exploiting recent advances in genomics 
Places: elucidating the role of environment in GI disease outbreaks 
Pathways: understanding transmission of GI infection to and between 
people 
The microbiome: the role of microbial communities in GI infections 
Blood-borne and 
sexually transmitted 
infections 
Understanding risk and risk reduction for STIs and BBVs  
Reducing the burden of undiagnosed STIs and BBVs 
Improving the care and management of people with STIs and BBVs 
Healthcare 
associated 
infections and 
antimicrobial 
resistance 
Applied molecular bacteriology  
Applied data linkage, syndromic surveillance and modelling  
Innovations in behaviour change, technology and patient safety to 
improve infection prevention and antimicrobial use 
Organisational change, sustainability and evaluation 
Improved data linkage, surveillance, data analysis and modelling  
Translation of pathogen genome sequencing 
Interventions, assessment and delivery 
Development of 
modelling 
methodology 
Respiratory infections, HIV and sexually transmitted infections 
Emerging threats   
Behavioural science and health economics 
Integrated genetic and epidemiological analysis informatics, Platforms 
and software  
Tools, training and capacity building   
Evaluation of 
interventions 
Economic evaluation and modelling 
Population studies  
Primary care 
Evidence synthesis 
Behavioural science 
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Annex C 
Glossary of acronyms  
 
AHSN   Academic Health Sciences Network 
CASP   Critical Appraisal Skills Programme 
CLAHRC   Collaboration for Leadership in Applied Health Research and Care 
CPRD   Clinical Practice Research Datalink 
CRN    Clinical Research Network 
CTU   Clinical Trials Unit 
DH    Department of Health, England 
DH HRP PRUs DH Health Research Programme Policy Research Units  
ESRC   Economic and Social Research Council 
GBD   Global Burden of Disease 
HEE   Health Education England 
HSC IC  Health and Social Care Information Centre 
HRA    Health Research Authority 
JLA PSP  James Lind Alliance Priority-Setting Partnership 
MRC    Medical Research Council 
NIHR    National Institute for Health Research 
NIHR HPRU   NIHR Health Protection Research Unit 
NIHR SPHR   NIHR School for Public Health Research  
NOCRI   NIHR Office for Coordination of Clinical Research Infrastructure 
PHE    Public Health England 
PPI/E   Patient and Public Involvement and Engagement 
UKCRC   UK Clinical Research Collaboration 
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Annex D 
Development of this strategy included extensive engagement with public health research, 
practice and academia within PHE and externally and a 12-week public consultation 
(December 2014 to March 2015).  
 
Summary of comments provided through the public consultation: 
 
Topics 
 
  Partnership Wide range of potential partnerships across the sectors requires 
further exploration and clarity, ie PPI; HEIs: NHS, professional 
bodies and voluntary sector as partners.  
Transparency over PHE's role and leadership, relationship 
between national/local. 
 
Co-production Build on what is already there; nature of international scope;  
PH broader than PH specialty 
  National/local Build on existing local research; Links to 'place-based' PH; 
access to data  
and intelligence at local level 
  Language, terminology,  
clarity and structure 
Lack of clear definitions; challenges section not set out clearly, 
or differentiated  
from 'aims'; needs explanatory text or link between 
‘opportunities' and 'challenges' in relation to strategic priorities; 
need clear and realistic goals; needs clear framework; how will 
outcomes be measured?;  
build on what is already known and invest where there is an 
identified gap 
  Wider knowledge cycle  
and translation 
Less focus on 'primary' research; links between research and 
practice; identify uncertainties; avoid centralisation of expertise 
in data and statistics; access to and use of research 
Evaluation Need for robust evaluation methodologies and research outputs;  
need for evaluation research to be recognised in HEI metrics;  
need for evaluation research strategies at national level 
 
Workforce Better co-ordination of existing support and resources;  
role of PHE in supporting academic PH through specialty 
training; more detail needed on how PHE will support academic 
PH given current resource constraints; need 'entry' points for PH 
research careers;  
clarify scope of PHE in research career development 
  Funding Role of PHE in funding research; funding incentives, and issues 
for PH academic research; collaboration on research priorities 
and funding; visibility of research funding opportunities; visibility 
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of research funded and progress 
Scope Scope of PHE role: leadership; role of PHE re technologies; 
need to broaden disciplines relating to wider determinants; 
access to data; role in addressing cultural perspectives; 
prioritisation and funding 
 
Pathway/model 
(These comments relate  
to the knowledge cycle 
that is included in the 
PHE knowledge 
strategy) 
Clarify relationships within model; add detail to aid clarity for  
all partners; consider existing models; add step to relate to  
priorities; overcomplicated and doesn't flow; Incorporate a 
reflexive loop; develop a shared narrative 
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Annex E 
The following individuals and organisations external to PHE provided comments on this 
strategy through the public consultation: 
Academy of Medical Sciences 
Alzheimer’s Research UK 
Animal and Plant Health Agency  
Association of Directors of Public Health 
Asthma UK 
British Association for the Study of Community Dentistry  
British Heart Foundation  
Cancer Research UK 
City of York Council 
College of Occupational Therapists 
Cornwall Council 
Council for Allied Health Professionals Research (CAHPR)  
Durham University, Professor of Health Policy and Management, and Director 
Centre for Public Policy and Health 
Food and Environment Research Agency 
Keele University, Research Institute for Primary Care and Health Sciences 
King’s College London, Department of Primary Care and Public Health Sciences 
Lincolnshire County Council 
Newcastle University, Institute of Health & Society 
National Institute for Biological Standards and Control, Director  
National Institute for Health and Care Excellence 
NHS England, Pandemic Influenza Resilience Manager 
NHS R&D Forum Primary Care Working Group 
NIHR Public Health Research Programme, Director 
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Research Councils UK   
Society and College of Radiographers 
The PHG Foundation 
The Society and College of Radiographers  
UCL School of Life and Medical Sciences 
University of Birmingham, CLAHRC-WM 
University of Cambridge: Cambridge Institute of Public Health, the Cambridge Public 
Health Network and Cambridge Infectious Diseases University of Nottingham, 
Associate Professor and Consultant in Public Health 
University of Manchester, Director of the Institute of Population Health 
University of Nottingham, Associate Professor and Consultant in Public Health 
University of Warwick Medical School, Public Health academics  
Warrington Local Authority, Public Health Team  
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